GENEPOD THERAPEUTICS AB has a total of 13 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are ISIS PHARMACEUTICAL INC, MCSWIGGEN JAMES and KIDO TSUNEO.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 1 | |
#2 | Brazil | 1 | |
#3 | Canada | 1 | |
#4 | Chile | 1 | |
#5 | China | 1 | |
#6 | Colombia | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | New Zealand | 1 | |
#12 | Russian Federation | 1 | |
#13 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Enzymes | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Kirik Deniz | 11 |
#2 | Bjorklund Tomas | 5 |
#3 | Bjorklund Anders | 5 |
#4 | Bjoerklund Tomas | 2 |
#5 | Björklund Anders | 2 |
#6 | Bjoerklund Anders | 2 |
#7 | Björklund Tomas | 2 |
#8 | Anders Bjoerklund | 1 |
#9 | Berklund Anders | 1 |
#10 | Tomas Bjoerklund | 1 |
Publication | Filing date | Title |
---|---|---|
KR20120089743A | Novel viral vector construct for neuron specific optimized continuous dopa synthesis in vivo |